Overview

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the efficacy and safety of oral YM150 for 52 weeks in patients with a history of venous thromboembolism.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Darexaban